Ebola Outbreak 2014 - News, Updates and Related Investments Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: statesidereport	8/4/2014 10:52:54 AM
	of 608

The Tekmira Ebola Trade May Already Be OverBy: Adam Feuerstein Follow\| 08/04/14 - 10:07 AM EDT If this CNN story is true, traders playing the Ebola scare by buying Tekmira Pharmaceuticals ( TKMR) picked the wrong horse. Mapp Biopharmaceuticals, a privately held drug company in San Diego, might already have an effective therapy against the deadly virus racing through Africa. CNN is reporting that the two U.S. aid workers infected with Ebola were treated -- and their lives saved while still in Africa -- with an experimental drug known as ZMapp developed by Mapp Biopharma. The drug had never been tried on humans before but had shown promise in animal studies, CNN reports. Here's CNN describing how the two aid workers were treated with the Mapp Biopharma drug: The ZMapp vials reached the hospital in Liberia where Brantly and Writebol were being treated Thursday morning. Doctors were instructed to allow the vials to thaw naturally without any additional heat. It was expected that it would be eight to 10 hours before the medicine could be given, according to a source familiar with the process. [iframe id="google_ads_iframe_/367/tsc-global/global-index_20" name="google_ads_iframe_/367/tsc-global/global-index_20" width="585" height="55" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" style="border-width: 0px; vertical-align: bottom;"][/iframe] Brantly asked that Writebol be given the first dose because he was younger and he thought he had a better chance of fighting it, and she agreed. However, as the first vial was still thawing, Brantley's condition took a sudden turn for the worse. Brantly began to deteriorate and developed labored breathing. He told his doctors, "I am going to die," according to a source with firsthand knowledge of the situation. Knowing his dose was still frozen, Brantly asked if he could have Writebol's now-thawed medication. It was brought to his room and administered through an IV. Within an hour of receiving the medication, Brantly's condition was nearly reversed. His breathing improved; the rash over his trunk faded away. One of his doctors described the events as "miraculous." By the next morning, Brantly was able to take a shower on his own before getting on a specially designed Gulfstream air ambulance jet to be evacuated to the United States. Writebol also received a vial of the medication. Her response was not as remarkable, according to sources familiar with the treatment. However, doctors on Sunday administered Writebol a second dose of the medication, which resulted in significant improvement. She was stable enough to be evacuated back to the United States and is expected to arrive before noon Tuesday. One point of clarification for traders looking for the next ebola trade: Mapp Biopharma is not MAP Pharmaacquired by Allergan ( AGN). Different companies entirely. [iframe id="google_ads_iframe_/367/tsc-global/global-index_21" name="google_ads_iframe_/367/tsc-global/global-index_21" width="585" height="64" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" style="border-width: 0px; vertical-align: bottom;"][/iframe]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next